Company Filing History:
1 out of 1,777 
1 out of 1,384 Years Active: 2005
Title: **Frederick Christian Grønvald: Innovator in Meiosis Regulation**
Introduction
Frederick Christian Grønvald, based in Vedbæk, Denmark, is an accomplished inventor known for his contributions to the field of reproductive biology. With a focus on meiosis regulation, he has developed innovative solutions that have the potential to impact both human and animal biology significantly.
Latest Patents
Grønvald holds a patent for "Meiosis regulating compounds," which describes certain novel sterol derivatives designed to regulate meiosis in both oocytes and male germ cells. This breakthrough could lead to advancements in fertility treatments and the understanding of reproductive processes.
Career Highlights
Grønvald has worked with prominent companies in the biotechnology and pharmaceutical sectors, including Novo Nordisk A/S and Schering Aktiengesellschaft. His expertise in the field has paved the way for critical advancements in reproductive health.
Collaborations
Throughout his career, Grønvald has collaborated with talented professionals, including colleagues Peter Faarup and Thorsten Blume. These collaborations have enriched his research and expanded the impact of his innovations.
Conclusion
Frederick Christian Grønvald's contributions to meiosis regulation highlight the importance of innovation in the life sciences. With his groundbreaking patent and collaborative efforts, he is poised to play a significant role in future advancements in reproductive biology.